de Sanjose S: HPV prevention series. Infect Agent Cancer. 2012, 7 (1): 37-10.1186/1750-9378-7-37.
Article
PubMed
PubMed Central
Google Scholar
Tomljenovic L, Shaw CA, Spinosa JP: Human Papillomavirus (HPV) Vaccines as an option for preventing cervical malignancies: (How) effective and safe?. Curr Pharm Des. 2012, CPD-EPUB-20120924-13-Epub ahead of print
Google Scholar
Tomljenovic L, Shaw CA: Who profits from uncritical acceptance of biased estimates of vaccine efficacy and safety?. Am J Public Health. 2012, 102 (9): e13-e14. 10.2105/AJPH.2012.300837.
Article
PubMed
PubMed Central
Google Scholar
Tomljenovic L, Shaw CA: Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?. Ann Med. 2011, 10.3109/07853890.2011.645353.
Google Scholar
Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, Shiboski S: Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol. 2010, 116 (6): 1373-1380. 10.1097/AOG.0b013e3181fe777f.
Article
PubMed
PubMed Central
Google Scholar
Castle PE, Schiffman M, Wheeler CM, Solomon D: Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009, 113 (1): 18-25.
Article
PubMed
PubMed Central
Google Scholar
Castle PE, Stoler MH, Solomon D, Schiffman M: The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol. 2007, 127 (5): 805-815. 10.1309/PT3PNC1QL2F4D2VL.
Article
PubMed
Google Scholar
Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE: Impact of improved classification on the association of human papillomavirus with cervical precancer. Am J Epidemiol. 2009, 171 (2): 155-163.
Article
PubMed
PubMed Central
Google Scholar
Carreon JD, Sherman ME, Guillén D, Solomon D, Herrero R, Jerónimo J, Wacholder S, Rodríguez AC, Morales J, Hutchinson M, et al: CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of populationbased cervical samples. Int J Gynecol Pathol. 2007, 26 (4): 441-446. 10.1097/pgp.0b013e31805152ab.
Article
PubMed
Google Scholar
Schiffman M, Rodriguez AC: Heterogeneity in CIN3 diagnosis. Lancet Oncol. 2008, 9 (5): 404-406. 10.1016/S1470-2045(08)70110-4.
Article
PubMed
Google Scholar
Gerhardus A, Razum O: A long story made too short: surrogate variables and the communication of HPV vaccine trial results. J Epidemiol Community Health. 2010, 64 (5): 377-378. 10.1136/jech.2009.090183.
Article
PubMed
Google Scholar
Tomljenovic L, Shaw CA: Too fast or not too fast: the FDA’s approval of Merck’s HPV vaccine gardasil. J Law Med Ethics. 2012, 40 (3): 673-681.
Article
PubMed
Google Scholar
Tomljenovic L, Shaw CA: No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?. J Intern Med. 2012, 272 (5): 514-515.
Article
PubMed
CAS
Google Scholar
Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H, Qureshi AI: Guillain-Barre syndrome after Gardasil vaccination: data from vaccine adverse event reporting system 2006–2009. Vaccine. 2011, 29 (5): 886-889. 10.1016/j.vaccine.2010.09.020.
Article
PubMed
Google Scholar
Mendoza Plasencia Z, Gonzalez Lopez M, Fernandez Sanfiel ML, Muniz Montes JR: Acute disseminated encephalomyelitis with tumefactive lesions after vaccination against human papillomavirus. Neurologia. 2010, 25 (1): 58-59. 10.1016/S0213-4853(10)70023-2.
Article
PubMed
CAS
Google Scholar
Wildemann B, Jarius S, Hartmann M, Regula JU, Hametner C: Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology. 2009, 72 (24): 2132-2133. 10.1212/WNL.0b013e3181aa53bb.
Article
PubMed
CAS
Google Scholar
DiMario FJ, Hajjar M, Ciesielski T: A 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus. J Child Neurol. 2010, 25 (3): 321-327. 10.1177/0883073809349322.
Article
PubMed
Google Scholar
Pugnet G, Ysebaert L, Bagheri H, Montastruc JL, Laurent G: Immune thrombocytopenic purpura following human papillomavirus vaccination. Vaccine. 2009, 27 (28): 3690-10.1016/j.vaccine.2009.04.004.
Article
PubMed
Google Scholar
Melo Gomes S, Glover M, Malone M, Brogan P: Vasculitis following HPV immunization. Rheumatology (Oxford). 2012, 2012-10.1093/rheumatology/kes168.
Google Scholar
Chang J, Campagnolo D, Vollmer TL, Bomprezzi R: Demyelinating disease and polyvalent human papilloma virus vaccination. J Neurol Neurosurg Psychiatry. 2011, 82 (11): 1296-1298. 10.1136/jnnp.2010.214924.
Article
PubMed
Google Scholar
McCarthy JE, Filiano J: Opsoclonus Myoclonus after human papilloma virus vaccine in a pediatric patient. Parkinsonism Relat Disord. 2009, 15 (10): 792-794. 10.1016/j.parkreldis.2009.04.002.
Article
PubMed
Google Scholar
Della Corte C, Carlucci A, Francalanci P, Alisi A, Nobili V: Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl. Vaccine. 2011, 29 (29–30): 4654-4656.
Article
PubMed
Google Scholar
Sutton I, Lahoria R, Tan IL, Clouston P, Barnett MH: CNS demyelination and quadrivalent HPV vaccination. Mult Scler. 2009, 15 (1): 116-119. 10.1177/1352458508096868.
Article
PubMed
CAS
Google Scholar
Tomljenovic L, Shaw AC: Death after quadrivalent human papillomavirus (HPV) vaccination: causal or coincidental?. Pharm Reg Affairs. 2012, S12: 001-104172/2167-7689S12-001.
Google Scholar
Tomljenovic L, Shaw CA: Mandatory HPV vaccination. JAMA. 2012, 307 (3): 254-author reply 254–255
Article
PubMed
CAS
Google Scholar
Spinosa JP, Riva C, Biollaz J: Letter to the editor response to the article of Luisa Lina Villa HPV prophylactic vaccination: the first years and what to expect from now, in press. Cancer Lett. 2011, 304 (1): 70-10.1016/j.canlet.2011.01.024.
Article
PubMed
CAS
Google Scholar
U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee (VRBPAC): VRBPAC Background Document: Gardasil™ HPV Quadrivalent Vaccine. May 18. 2006, [http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B3.pdf]., VRBPAC Meeting
Beller U, Abu-Rustum NR: Cervical cancers after human papillomavirus vaccination. Obstet Gynecol. 2009, 113 (2 Pt 2): 550-552.
Article
PubMed
Google Scholar
Mello MM, Abiola S, Colgrove J: Pharmaceutical companies’ role in state vaccination policymaking: the case of human papillomavirus vaccination. Am J Public Health. 2012, 102 (5): 893-898. 10.2105/AJPH.2011.300576.
Article
PubMed
PubMed Central
Google Scholar
Comments
View archived comments (1)